Novartis Ag (NVS) Short-Term Debt repayments (2019 - 2025)
Historic Short-Term Debt repayments for Novartis Ag (NVS) over the last 7 years, with Q4 2025 value amounting to -$73.0 million.
- Novartis Ag's Short-Term Debt repayments fell 138.89% to -$73.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$281.0 million, marking a year-over-year decrease of 725.19%. This contributed to the annual value of -$281.0 million for FY2025, which is 725.19% down from last year.
- Novartis Ag's Short-Term Debt repayments amounted to -$73.0 million in Q4 2025, which was down 138.89% from -$73.0 million recorded in Q3 2025.
- Over the past 5 years, Novartis Ag's Short-Term Debt repayments peaked at -$59.0 million during Q2 2024, and registered a low of -$80.0 million during Q1 2021.
- Over the past 5 years, Novartis Ag's median Short-Term Debt repayments value was -$68.0 million (recorded in 2024), while the average stood at -$69.8 million.
- As far as peak fluctuations go, Novartis Ag's Short-Term Debt repayments crashed by 1764.71% in 2021, and later surged by 2000.0% in 2022.
- Quarter analysis of 5 years shows Novartis Ag's Short-Term Debt repayments stood at -$80.0 million in 2021, then rose by 20.0% to -$64.0 million in 2022, then changed by 0.0% to -$64.0 million in 2023, then fell by 12.5% to -$72.0 million in 2024, then decreased by 1.39% to -$73.0 million in 2025.
- Its Short-Term Debt repayments was -$73.0 million in Q4 2025, compared to -$73.0 million in Q3 2025 and -$66.0 million in Q2 2025.